[go: up one dir, main page]

BR9608392A - Preparação multiparticulada de liberação controlada e forma de dosagem em tablete. - Google Patents

Preparação multiparticulada de liberação controlada e forma de dosagem em tablete.

Info

Publication number
BR9608392A
BR9608392A BR9608392-1A BR9608392A BR9608392A BR 9608392 A BR9608392 A BR 9608392A BR 9608392 A BR9608392 A BR 9608392A BR 9608392 A BR9608392 A BR 9608392A
Authority
BR
Brazil
Prior art keywords
dosage form
tablet dosage
release preparation
multiparticulate controlled
controlled
Prior art date
Application number
BR9608392-1A
Other languages
English (en)
Inventor
Herman Marder
Lawrence Kirschner
John J Steinke
Andrew D Kurtz
Poul Bertelsen
Nils Gjerlov Hansen
Thyge Borup Hjorth
Original Assignee
Church & Dwight Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Church & Dwight Co Inc filed Critical Church & Dwight Co Inc
Publication of BR9608392A publication Critical patent/BR9608392A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"PREPARAçãO MULTIPARTICULADA DE LIBERAçãO CONTROLADA E FORMA DE DOSAGEM EM TABLETE". Preparações de liberação controlada multiparticuladas incorporando um sal alcalinizante de potássio, de preferência bicarbonato de potássio, como um ingrediente ativo, que são adequadas para formação de formas de dosagem farmacêuticas para administração oral. Tais formas de dosagens são úteis para suplementação de potássio e para o tratamento de doenças degenerativas dos ossos ou cardiovasculares, por exemplo, osteoporose e hipertensão.
BR9608392-1A 1995-06-06 1996-06-06 Preparação multiparticulada de liberação controlada e forma de dosagem em tablete. BR9608392A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/472,693 US5674529A (en) 1995-06-06 1995-06-06 Alkalinizing potassium salt controlled release preparations
PCT/US1996/009016 WO1996039127A1 (en) 1995-06-06 1996-06-06 Alkalinizing potassium salt controlled release preparations

Publications (1)

Publication Number Publication Date
BR9608392A true BR9608392A (pt) 1999-11-30

Family

ID=23876566

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608392-1A BR9608392A (pt) 1995-06-06 1996-06-06 Preparação multiparticulada de liberação controlada e forma de dosagem em tablete.

Country Status (18)

Country Link
US (1) US5674529A (pt)
EP (1) EP0840598A4 (pt)
JP (1) JPH11506778A (pt)
KR (1) KR19990022537A (pt)
CN (1) CN1106837C (pt)
AR (1) AR003131A1 (pt)
AU (1) AU698784B2 (pt)
BR (1) BR9608392A (pt)
CA (1) CA2223281A1 (pt)
CO (1) CO4700033A1 (pt)
CZ (1) CZ288129B6 (pt)
HU (1) HUP9900856A2 (pt)
NO (1) NO312815B1 (pt)
NZ (1) NZ310138A (pt)
PL (1) PL323939A1 (pt)
SK (1) SK167797A3 (pt)
WO (1) WO1996039127A1 (pt)
ZA (1) ZA964427B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4759099A (en) * 1998-09-21 2000-03-23 Mcneil-Ppc, Inc. Heat stable antacid and antigas suspensions
JP5014554B2 (ja) * 2000-06-14 2012-08-29 ジェイカムアグリ株式会社 被覆生物活性粒状物の製造方法
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
KR20050005437A (ko) 2002-04-09 2005-01-13 플라멜 테크놀로지스 아목시실린의 변형 방출을 위한 마이크로캡슐 수성 현탁액형태의 경구 제약학적 제제
EP1492511B3 (fr) 2002-04-09 2012-05-02 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
FR2838647B1 (fr) * 2002-04-23 2006-02-17 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
WO2004091614A2 (en) * 2003-04-14 2004-10-28 Teva Pharmaceutical Industries Ltd. Stabilized amlodipine maleate formations
HUE038174T2 (hu) * 2007-10-12 2018-09-28 Ferring Int Center Sa Eljárás citromsavat, magnéziumoxidot, káliumbikarbonátot és nátriumpikoszulfátot tartalmazó gyógyszertermék elõállítására, ilyen eljárással elõállított szemcsés gyógyászati készítmény és köztitermékei
FR2967578B1 (fr) * 2010-11-18 2012-12-28 Advicenne Pharma Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
WO2025128724A1 (en) * 2023-12-12 2025-06-19 Arbert, Llc Coated inorganic salts and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US4140756A (en) * 1976-06-10 1979-02-20 Mead Johnson & Company Film-coated matrix core tablet
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
JPH0759499B2 (ja) * 1984-02-10 1995-06-28 ベンツォン ファーマ エイ／エス 拡散被覆された複合単位服用剤
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
US4863743A (en) * 1985-02-19 1989-09-05 Key Pharmaceuticals, Inc. Controlled release potassium chloride
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
US4822619A (en) * 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
DE68913311T2 (de) * 1988-10-21 1994-05-26 The Regents Of The University Of California, Oakland, Calif. Behandlung von Osteoporosis.
US5171583A (en) * 1988-10-21 1992-12-15 The Regents Of The University Of California Treatment of osteoporosis using potassium bicarbonate
US5498428A (en) * 1988-10-21 1996-03-12 The Regents Of The University Of California Treatment of hypertension by oral administration of potassium bicarbonate
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
US5077051A (en) * 1990-04-10 1991-12-31 Warner-Lambert Company Sustained release of active agents from bioadhesive microcapsules
US5445805A (en) * 1993-05-06 1995-08-29 Church & Dwight Co., Inc. Large potassium bicarbonate crystals and process for the preparation thereof

Also Published As

Publication number Publication date
PL323939A1 (en) 1998-04-27
AR003131A1 (es) 1998-07-08
EP0840598A1 (en) 1998-05-13
NZ310138A (en) 1999-04-29
KR19990022537A (ko) 1999-03-25
AU6047396A (en) 1996-12-24
US5674529A (en) 1997-10-07
CN1106837C (zh) 2003-04-30
NO312815B1 (no) 2002-07-08
CZ288129B6 (cs) 2001-04-11
NO975567L (no) 1998-02-05
SK167797A3 (en) 1998-06-03
EP0840598A4 (en) 2001-08-29
HUP9900856A2 (hu) 1999-08-30
CA2223281A1 (en) 1996-12-12
CO4700033A1 (es) 1998-12-29
WO1996039127A1 (en) 1996-12-12
ZA964427B (en) 1997-02-24
AU698784B2 (en) 1998-11-05
CZ389297A3 (cs) 1998-06-17
NO975567D0 (no) 1997-12-03
JPH11506778A (ja) 1999-06-15
CN1187121A (zh) 1998-07-08

Similar Documents

Publication Publication Date Title
FR11C0017I2 (fr) Utilisation de spinosad ou d'une formulation comprennant spinosad
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
BR9908438A (pt) Tabletes de desintegração rápida
NO995006D0 (no) Nye forbindelser
AU1227899A (en) Osmotic medicament releasing system
NO971206D0 (no) Forlenget-frigjöringsformulering
HUP0003121A2 (hu) Eljárás perorálisan alkalmazható, szabályozott hatóanyag-leadású szilárd gyógyszerkészítmények előállítására
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
BR9608392A (pt) Preparação multiparticulada de liberação controlada e forma de dosagem em tablete.
ES2098920T3 (es) Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina.
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
BR9610480A (pt) Inibição do fator alfa de necrose tumoral
NO20011211D0 (no) Multippel enhet for kontrollert mateffektuavhengig frigivelse av farmasøytiske preparater og fremgangsmÕter for fremstilling av samme
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
ATE273693T1 (de) Proteinhaltige arzneimittel
DE69501419D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Osteoporose enthaltend Xanthohumol
IL150528A0 (en) Ibuprofen containing active agent preparation
HUP0003840A2 (hu) Szabályozott hatóanyagleadású gyógyászati készítmények
CA2213261A1 (en) Therapeutics of osteoarthritis and inflammatory joint disease
BR9509975A (pt) Formulação farmacêutica
NO994395L (no) Stabilt, fast preparat som inneholder vitamin D3 og trikalsiumfosfat
HUP9901303A2 (hu) Gyógyszerkészítmény autoimmun betegségek kezelésére
GEP20043377B (en) Pharmaceutical Complex
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel

Legal Events

Date Code Title Description
FF Decision: intention to grant
FG9A Patent or certificate of addition granted
B24C Patent annual fee: request for for restoration
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time